XML 25 R8.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
$ in Millions
Common Stock [Member]
Additional Paid-In Capital [Member]
Retained Earnings [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Retained Earnings [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Treasury Stock [Member]
Noncontrolling Interests [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Total
Beginning balance at Dec. 31, 2019 $ 6 $ 5,049 $ (2) $ 10,592 $ (8) $ (8,571) $ 2 $ (2) $ 7,070
Beginning balance, common shares at Dec. 31, 2019 630,282,000                
Beginning balance, treasury shares at Dec. 31, 2019           (205,956,000)      
Equity roll forward                  
Consolidated net income       1,496         1,496
Other comprehensive income (loss), net of tax         47       47
Cash dividends declared       (927)         (927)
Equity-based compensation transactions, net   80   1   $ 91     172
Equity-based compensation transactions, net, shares           2,158,000      
Common stock repurchase program           $ (402)     $ (402)
Common stock repurchase program, shares           (3,687,000)     (3,687,000)
Other, net       (1)   $ 1      
Other, net, shares           4,000      
Ending balance at Dec. 31, 2020 $ 6 5,129   11,159 39 $ (8,881) 2   $ 7,454
Ending balance, common shares at Dec. 31, 2020 630,282,000               422,800,000
Ending balance, treasury shares at Dec. 31, 2020           (207,481,000)      
Equity roll forward                  
Consolidated net income       1,816     1   $ 1,817
Other comprehensive income (loss), net of tax         (22)       (22)
Cash dividends declared       (970)         (970)
Equity-based compensation transactions, net   110   (1)   $ 89     198
Equity-based compensation transactions, net, shares           2,049,000      
Common stock repurchase program   (70)       $ (1,280)     $ (1,350)
Common stock repurchase program, shares           (8,731,000)     (8,731,000)
Other, net             (1)   $ (1)
Other, net, shares           4,000      
Ending balance at Dec. 31, 2021 $ 6 5,169   12,004 17 $ (10,072) 2   $ 7,126
Ending balance, common shares at Dec. 31, 2021 630,282,000               416,100,000
Ending balance, treasury shares at Dec. 31, 2021           (214,159,000)     (214,158,636)
Equity roll forward                  
Consolidated net income       2,238     2   $ 2,240
Other comprehensive income (loss), net of tax         (86)       (86)
Cash dividends declared       (1,077)         (1,077)
Equity-based compensation transactions, net   75   2   $ 73     150
Equity-based compensation transactions, net, shares           1,555,000      
Common stock repurchase program   70       $ (1,570)     $ (1,500)
Common stock repurchase program, shares           (9,796,000)     (9,796,000)
Other, net             11   $ 11
Other, net, shares           4,000      
Ending balance at Dec. 31, 2022 $ 6 $ 5,314   $ 13,167 $ (69) $ (11,569) $ 15   $ 6,864
Ending balance, common shares at Dec. 31, 2022 630,282,000               407,900,000
Ending balance, treasury shares at Dec. 31, 2022           (222,396,000)     (222,396,166)